drugset / Trial / NCT00704379

Treatment Strategy to Prevent Mood Disorders Following Traumatic Brain Injury

NCT00704379

RandomizedParallel-groupTriple-blindPrevention

Summary

The purpose of this study is to examine the efficacy of sertraline to prevent the onset of mood and anxiety disorders during the first six months after traumatic brain injury.

Timeline

Start
2008-06
Primary completion
2014-04
Completion
2014-04

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Sertraline Small molecule 100 mg Oral